The Journal of Science Policy and Research Management
Online ISSN : 2432-7123
Print ISSN : 0914-7020
Special Issue
Company’s Expectation for the Collaboration with Star Scientists: the case of pharmaceutical industry
Ryo OKUYAMA
Author information
JOURNAL FREE ACCESS

2019 Volume 34 Issue 2 Pages 129-138

Details
Abstract

In a "science-based industry," where the outcomes of academic scientific research are leveraged for product development, it is quite important for companies to collaborate with star scientists. A variety of scientific knowledge and technologies provided by academic researchers have been utilized throughout the process of drug discovery, a typical case of science-based product development. This paper provides three cases of innovative drug discovery and development in Japanese pharmaceutical industry to demonstrate the significant contributions of star scientists. Based on the referred cases, I discuss how an industry-university-government collaboration can effectively translate academic research to product development. In addition, I introduce initiatives made by pharmaceutical companies for seeking opportunities of academic research collaboration and needs to search for future star scientists. I also highlight the expectations toward star scientists and potential collaboration issues from the perspective of pharmaceutical companies.

Content from these authors
2019 Japan Society for Research Policy and Innovation Management
Previous article Next article
feedback
Top